2022. Inhibition of Toll-like Receptor-4 expression for amelioration of myocardial injury in diabetes: A meta-analysis. Clinics. 77, (Nov. 2022), 100137. DOI:https://doi.org/10.1016/j.clinsp.2022.100137.